The relationship between tumors and the lumphatics: What more is there to know?

Lymphology

Volumn 39, Issue 2, 2006, Pages 62-68

  Sleeman, Jonathan P ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Anti lymphangiogenesis; Cancer; Lymphangiogenesis; Metastasis; VEGF C; VEGF D; VEGFR 3

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SCATTER FACTOR; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR; TUMOR CELL; VASCULARIZATION; ANIMAL; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; NEOPLASMS;

EID: 33745977072     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Sleeman, JP: The lymph node as a bridgehead in the metastatic dissemination of tumors. Recent Results Cancer Res. 157 (2000), 55-81.
2. Sleeman, JP, J Krishnan, V Kirkin, et al: Markers for the lymphatic endothelium: in search of the holy grail? Micro. Res. Tech. 55 (2001), 61-69.
3. Alitalo, K, T Tammela, TV Petrova: Lymphangiogenesis in development and human disease. Nature 438 (2005), 946-953.
4. Cao, Y: Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat. Rev. Cancer 5 (2005), 735-743.
5. He, Y, T Karpanen, K Alitalo: Role of lymphangiogenic factors in tumor metastasis. Biochim. Biophys. Acta 1654 (2004), 3-12.
6. Thiele, W, JP Sleeman: Tumor-induced lymphangiogenesis: a target for cancer therapy? J. Biotechnology (2006).
7. Achen, MG, BK McColl, SA Stacker: Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7 (2005), 121-127.
8. Pepper, MS: Lymphangiogenesis and tumor metastasis: myth or reality? Clin. Cancer Res. 7 (2001), 462-468.
9. Agarwal, B, R Saxena, A Morimiya, et al: Lymphangiogenesis does not occur in breast cancer. Am. J. Surg. Pathol. 29 (2005), 1449-1455.
10. Achen, MG, SA Stacker: Tumor lymphangiogenesis and metastatic spread - new players begin to emerge. Int. J. Cancer (2006).
11. Maula, SM, M Luukkaa, R Grenman, et al: Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res. 63 (2003), 1920-1926.
12. Franchi, A, O Gallo, D Massi, et al: Tumor lymphangiogenesis in head and neck squamous cell carcinoma: a morphometric study with clinical correlations. Cancer 101 (2004), 973-978.
13. Schledzewski, K, M Falkowski, G Moldenhauer, et al: Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J. Pathol. 209 (2006), 67-77.
14. Van Trappen, PO, D Steele, DG Lowe, et al: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J. Pathol. 201 (2003), 544-554.
15. Hirakawa, S, S Kodama, R Kunstfeld, et al: VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201 (2005), 1089-1099.
16. Kajiya, K, S Hirakawa, B Ma, et al: Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J. 24 (2005), 2885-2895.
17. Cao, R, MA Bjorndahl, MI Gallego, et al: Hepatocyte growth factor is a novel lymphangiogenic factor with an indirect mechanism of action. Blood 107 (2006), 3531-3536.
18. Cursiefen, C, L Chen, LP Borges, et al: VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113 (2004), 1040-1050.
19. Bjorndahl, MA, R Cao, JB Burton, et al: Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 65 (2005), 9261-9268.
20. Huang, XZ, JF Wu, R Ferrando, et al: Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol. Cell. Biol. 20 (2000), 5208-5215.
21. Vlahakis, NE, BA Young, A Atakilit, et al: The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J. Biol. Chem. 280 (2005), 4544-4552.
22. Orian-Rousseau, V, L Chen, JP Sleeman, et al: CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev. 16 (2002), 3074-3086.
23. Salameh, A, F Galvagni, M Bardelli, et al: Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways. Blood 106 (2005), 3423-3431.
24. Yong, C, EA Bridenbaugh, DC Zawieja, et al: Microarray analysis of VEGF-C responsive genes in human lymphatic endothelial cells. Lymphatic Res. Biol. 3 (2005), 183-207.
25. Petrova, TV, T Makinen, TP Makela, et al: Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21 (2002), 4593-4599.
26. Hong, YK, N Harvey, YH Noh, et al: Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 225 (2002), 351-357.
27. Paavonen, K, P Puolakkainen, L Jussila, et al: Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am. J. Pathol. 156 (2000), 1499-1504.
28. Hamada, K, Y Oike, N Takakura, et al: VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood 96 (2000), 3793-3800.
29. Fernandez Pujol, B, FC Lucibello, M Zuzarte, et al: Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. Eur. J. Cell Biol. 80 (2001), 99-110.
30. Schoppmann, SF, P Birner, J Stockl, et al: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161 (2002), 947-956.
31. Spliet, WG, E Aronica, M Ramkema, et al: Immunohistochemical localization of vascular endothelial growth factor receptors-1, -2 and -3 in human spinal cord: altered expression in amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 30 (2004), 351-359.
32. Witmer, AN, J Dai, HA Weich, et al: Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia. J. Histochem. Cytochem. 50 (2002), 767-777.
33. Witmer, AN, HG Blaauwgeers, HA Weich, et al: Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest. Ophthalmol. Vis. Sci. 43 (2002), 849-857.